Encouraging preliminary findings with a new miniCRISPR using a nanoCAS brings hope for previously incurable diseases such as Duchenne muscular dystrophy. The miniCRISPR can reach and edit previously inaccessible tissue including muscle.
Source:
Science 31 January 2025;
bioRxiv preprint (not peer reviewed)
bioRxiv preprint (not peer reviewed)
No comments:
Post a Comment